BlackRock, Inc. 13D and 13G filings for AngioDynamics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | AngioDynamics, Inc. ANGO |
BlackRock Inc. BLK |
2,918,422 7.200% |
-1,023,208 (-25.96%) |
Filing |
| 2025-02-05 5:28 pm Sale |
2024-12-31 | 13G | AngioDynamics, Inc. ANGO |
BlackRock Inc. BLK |
3,941,630 9.700% |
-718,789 (-15.42%) |
Filing |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | AngioDynamics, Inc. ANGO |
BlackRock Inc. BLK |
4,660,419 11.500% |
0 (Unchanged) |
Filing |
| 2024-10-23 5:04 pm Sale |
2024-09-30 | 13G | AngioDynamics, Inc. ANGO |
BlackRock Inc. BLK |
4,660,419 11.500% |
-383,679 (-7.61%) |
Filing |
| 2024-01-23 4:14 pm Purchase |
2023-12-31 | 13G | AngioDynamics, Inc. ANGO |
BlackRock Inc. BLK |
5,044,098 12.700% |
882,214 (+21.20%) |
Filing |
| 2023-10-06 2:34 pm Sale |
2023-09-30 | 13G | AngioDynamics, Inc. ANGO |
BlackRock Inc. BLK |
4,161,884 10.500% |
-2,552,013 (-38.01%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | AngioDynamics, Inc. ANGO |
BlackRock Inc. BLK |
6,713,897 17.200% |
0 (Unchanged) |
Filing |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | AngioDynamics, Inc. ANGO |
BlackRock Inc. BLK |
6,713,897 17.200% |
434,062 (+6.91%) |
Filing |
| 2022-01-28 1:54 pm Purchase |
2021-12-31 | 13G | AngioDynamics, Inc. ANGO |
BlackRock Inc. BLK |
6,279,835 16.200% |
7,002 (+0.11%) |
Filing |
| 2021-01-25 4:49 pm Sale |
2020-12-31 | 13G | AngioDynamics, Inc. ANGO |
BlackRock Inc. BLK |
6,272,833 16.500% |
-38,884 (-0.62%) |
Filing |